Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B
Diana G. Ferreira, Mariana Temido‐Ferreira, Hugo Vicente Miranda, et al.
Nature Neuroscience (2017) Vol. 20, Iss. 11, pp. 1569-1579
Closed Access | Times Cited: 247

Showing 1-25 of 247 citing articles:

Dementia with Lewy bodies: an update and outlook
Tiago F. Outeiro, David J. Koss, Daniel Erskine, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 298
Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease
Huiqin Zhang, Wei Wei, Ming Zhao, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 9, pp. 2181-2192
Open Access | Times Cited: 292
Prions, prionoids and protein misfolding disorders
Claudia Scheckel, Adriano Aguzzi
Nature Reviews Genetics (2018) Vol. 19, Iss. 7, pp. 405-418
Closed Access | Times Cited: 286
α-Synuclein strains target distinct brain regions and cell types
Angus Lau, Raphaella W. L. So, Heather H. C. Lau, et al.
Nature Neuroscience (2019) Vol. 23, Iss. 1, pp. 21-31
Open Access | Times Cited: 245
Meningeal γδ T cell–derived IL-17 controls synaptic plasticity and short-term memory
Miguel Ribeiro, Helena C. Brigas, Mariana Temido‐Ferreira, et al.
Science Immunology (2019) Vol. 4, Iss. 40
Open Access | Times Cited: 240
α-Synuclein pathology in Parkinson’s disease and related α-synucleinopathies
Michael X. Henderson, John Q. Trojanowski, Virginia M.‐Y. Lee
Neuroscience Letters (2019) Vol. 709, pp. 134316-134316
Open Access | Times Cited: 228
Dopamine, Oxidative Stress and Protein–Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases
Enrico Monzani, Stefania Nicolis, Simone Dell’Acqua, et al.
Angewandte Chemie International Edition (2018) Vol. 58, Iss. 20, pp. 6512-6527
Closed Access | Times Cited: 217
The Role of α-Synuclein Oligomers in Parkinson’s Disease
Xiaoyu Du, Xi-xiu Xie, Rui‐tian Liu
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8645-8645
Open Access | Times Cited: 167
Amyloid-type Protein Aggregation and Prion-like Properties of Amyloids
Dieter Willbold, Birgit Strodel, Gunnar F. Schröder, et al.
Chemical Reviews (2021) Vol. 121, Iss. 13, pp. 8285-8307
Open Access | Times Cited: 153
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
Luís M. A. Oliveira, Thomas Gasser, Robert H. Edwards, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 114
Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies
Roberta Cascella, Alessandra Bigi, Nunilo Cremades, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 70
Spatiotemporal modulations in heterotypic condensates of prion and α-synuclein control phase transitions and amyloid conversion
Aishwarya Agarwal, Lisha Arora, K. Sandeep, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 70
Advances in understanding the function of alpha-synuclein: implications for Parkinson’s disease
Paolo Calabresi, Giulia Di Lazzaro, Gioia Marino, et al.
Brain (2023) Vol. 146, Iss. 9, pp. 3587-3597
Open Access | Times Cited: 60
Alpha Synuclein: Neurodegeneration and Inflammation
Gianluigi Forloni
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5914-5914
Open Access | Times Cited: 57
Terahertz Photons Improve Cognitive Functions in Posttraumatic Stress Disorder
Yun Yu, Kaijie Wu, Yang Xiao, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 52
Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions
Grace m. Kuo, Ramhari Kumbhar, W. Frank Blair, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors
Mariana Temido‐Ferreira, Diana G. Ferreira, Vânia L. Batalha, et al.
Molecular Psychiatry (2018) Vol. 25, Iss. 8, pp. 1876-1900
Open Access | Times Cited: 156
Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration
Veronica Ghiglieri, Valeria Calabrese, Paolo Calabresi
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 141
PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins
Grant T. Corbett, Zemin Wang, Wei Hong, et al.
Acta Neuropathologica (2019) Vol. 139, Iss. 3, pp. 503-526
Open Access | Times Cited: 140
Crucial role of protein oligomerization in the pathogenesis of Alzheimer's and Parkinson's diseases
Minee L. Choi, Sonia Gandhi
FEBS Journal (2018) Vol. 285, Iss. 19, pp. 3631-3644
Open Access | Times Cited: 119
Caffeine and Parkinson’s Disease: Multiple Benefits and Emerging Mechanisms
Xiangpeng Ren, Jiang‐Fan Chen
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 115
ɑ-Synuclein strains and seeding in Parkinson’s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences
Wouter Peelaerts, Luc Bousset, Veerle Baekelandt, et al.
Cell and Tissue Research (2018) Vol. 373, Iss. 1, pp. 195-212
Open Access | Times Cited: 111
Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein
Luis Aragão Gomes, Silvia Andrea Hipp, Ajeet Rijal Upadhaya, et al.
Acta Neuropathologica (2019) Vol. 138, Iss. 6, pp. 913-941
Closed Access | Times Cited: 94
Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo
Darren J. Schofield, Lorraine Irving, Laura Calò, et al.
Neurobiology of Disease (2019) Vol. 132, pp. 104582-104582
Open Access | Times Cited: 92
The function of the cellular prion protein in health and disease
Joel C. Watts, Matthew E.C. Bourkas, Hamza Arshad
Acta Neuropathologica (2017) Vol. 135, Iss. 2, pp. 159-178
Closed Access | Times Cited: 88
Page 1 - Next Page

Scroll to top